Categories: BioTechHealthTechMedtechPlatformResearchServiceTechnology
Location: United States, Connecticut, Farmington
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.07.2022 | - | $800K | - |
Mentions in press and media 5
| Date | Title | Description |
| 24.10.2024 | Intus Bio Launches GutID™ Microbiome Test, Bringing the Power of Its Breakthrough Titan-1™ Platform to Patients and Consumers | The Intus Bio GutID™ Microbiome Test
New test provides critical insights for optimizing gut health and delivering potential relief for those suffering from digestive issues
FARMINGTON, Conn., Oct. 24, 2024 /PRNewswire-PRWeb/ -- Intus Biosci... |
| 28.06.2023 | Intus Bio Strengthens Industry Leading Microbiome Platform with Acquisition of Pattern Genomics | FARMINGTON, Conn. (PRWEB) June 28, 2023
Intus Biosciences, LLC (Intus Bio), creators of the industry-leading Titan-1™ microbiome research and testing platform, has announced the strategic acquisition of Pattern Genomics, a developer of adva... |
| 27.10.2022 | Shoreline Biome Announces Name Change to Intus Biosciences | FARMINGTON, Conn. (PRWEB) October 27, 2022
Shoreline Biome, the developer of the industry-leading Titan-1TM microbiome research, discovery and testing platform, announced today that it has changed its name to Intus Biosciences.
Intus—a Lati... |
| - | Do you need a $599 gut test? What your poop can tell you about your health | It’s a gut-wrenching problem.
Research indicates that around two-thirds of US adults struggle with persistent tummy troubles like gas, bloating and abdominal pain — and few seek medical help.
Some take matters into their own hands by keepin... |
| - | Intus Bio | “Our validated and proprietary Titan-1™ platform for studying the microbiome is a generation ahead of the latest 16S and shotgun metagenomics based approaches” |
Reviews 0
